Nevertheless, evidence suggests that in TAMs and MDSCs, oxidative stress can activate IκB kinase (IKK) by promoting ROS production, leading to the degradation of IκB protein, the release of NF-κB, upregulation of PD-L1, and ultimately reduced anti-tumor T cell activity (194, 195). Here, NFKB1 is linked to neoplasm.